Global Embolization Particle Competitive Landscape Professional Research Report 2025
Description
Global Embolization Particle Competitive Landscape Professional Research Report 2025
Research Summary
Embolization particles, also known as embolic agents, are tiny materials used in medical procedures to block or occlude blood vessels or arteries. They are typically administered to manage various medical conditions, such as controlling bleeding, treating vascular malformations, or blocking the blood supply to tumors. These particles can be made of different materials, such as gelatin foam, microspheres, or coils, and are chosen based on the specific medical purpose. When introduced into the targeted blood vessel, embolization particles create a blockage, restricting or completely cutting off blood flow. This technique is employed to treat various medical conditions, often minimizing the need for more invasive surgeries and reducing the risk of complications.
According to DIResearch's in-depth investigation and research, the global Embolization Particle market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Embolization Particle include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, INterface BIOmaterials B.V., HENGRUI Medical, Alicon etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Embolization Particle. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Embolization Particle market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Embolization Particle market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Embolization Particle industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Embolization Particle Include:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
INterface BIOmaterials B.V.
HENGRUI Medical
Alicon
Embolization Particle Product Segment Include:
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Embolization Particle Product Application Include:
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Embolization Particle Industry PESTEL Analysis
Chapter 3: Global Embolization Particle Industry Porter’s Five Forces Analysis
Chapter 4: Global Embolization Particle Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Embolization Particle Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Embolization Particle Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Embolization Particle Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Embolization Particle Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Embolization Particle Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Embolization Particle Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Embolization Particle Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Embolization Particle Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Embolization Particle Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Embolization Particle Product by Type
- 1.2.1 Microspheres
- 1.2.2 Particles (e.g. PVA Particles, Gelfoam Particles)
- 1.2.3 Drug-eluting Beads (DEBs)
- 1.2.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
- 1.3 Embolization Particle Product by Application
- 1.3.1 Uterine Fibroid Embolization
- 1.3.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
- 1.3.3 Liver Tumor Embolization
- 1.3.4 Trauma Embolization
- 1.3.5 Others
- 1.4 Global Embolization Particle Market Revenue and Sales Analysis
- 1.4.1 Global Embolization Particle Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Embolization Particle Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Embolization Particle Market Sales Price Trend Analysis (2020-2032)
- 1.5 Embolization Particle Industry Trends and Innovation
- 1.5.1 Embolization Particle Industry Trends and Innovation
- 1.5.2 Embolization Particle Market Drivers and Challenges
- 2 Embolization Particle Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Embolization Particle Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Embolization Particle Market Analysis by Regions
- 4.1 Embolization Particle Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Embolization Particle Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Embolization Particle Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Embolization Particle Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Embolization Particle Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Embolization Particle Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Embolization Particle Sales Forecast by Region (2026-2032)
- 4.4 Global Embolization Particle Sales Price Trend Analysis (2020-2032)
- 5 Global Embolization Particle Market Size by Type and Application
- 5.1 Global Embolization Particle Market Size by Type
- 5.1.1 Global Embolization Particle Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Embolization Particle Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Embolization Particle Market Size by Application
- 5.2.1 Global Embolization Particle Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Embolization Particle Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Embolization Particle Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Embolization Particle Market Size by Type
- 6.3.1 North America Embolization Particle Sales by Type (2020-2032)
- 6.3.2 North America Embolization Particle Revenue by Type (2020-2032)
- 6.4 North America Embolization Particle Market Size by Application
- 6.4.1 North America Embolization Particle Sales by Application (2020-2032)
- 6.4.2 North America Embolization Particle Revenue by Application (2020-2032)
- 6.5 North America Embolization Particle Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Embolization Particle Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Embolization Particle Market Size by Type
- 7.3.1 Europe Embolization Particle Sales by Type (2020-2032)
- 7.3.2 Europe Embolization Particle Revenue by Type (2020-2032)
- 7.4 Europe Embolization Particle Market Size by Application
- 7.4.1 Europe Embolization Particle Sales by Application (2020-2032)
- 7.4.2 Europe Embolization Particle Revenue by Application (2020-2032)
- 7.5 Europe Embolization Particle Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Embolization Particle Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Embolization Particle Market Size by Type
- 8.3.1 China Embolization Particle Sales by Type (2020-2032)
- 8.3.2 China Embolization Particle Revenue by Type (2020-2032)
- 8.4 China Embolization Particle Market Size by Application
- 8.4.1 China Embolization Particle Sales by Application (2020-2032)
- 8.4.2 China Embolization Particle Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Embolization Particle Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Embolization Particle Market Size by Type
- 9.3.1 APAC (excl. China) Embolization Particle Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Embolization Particle Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Embolization Particle Market Size by Application
- 9.4.1 APAC (excl. China) Embolization Particle Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Embolization Particle Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Embolization Particle Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Embolization Particle Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Embolization Particle Market Size by Type
- 10.3.1 Latin America Embolization Particle Sales by Type (2020-2032)
- 10.3.2 Latin America Embolization Particle Revenue by Type (2020-2032)
- 10.4 Latin America Embolization Particle Market Size by Application
- 10.4.1 Latin America Embolization Particle Sales by Application (2020-2032)
- 10.4.2 Latin America Embolization Particle Revenue by Application (2020-2032)
- 10.5 Latin America Embolization Particle Market Size by Country
- 10.6 Latin America Embolization Particle Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Embolization Particle Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Embolization Particle Market Size by Type
- 11.3.1 Middle East & Africa Embolization Particle Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Embolization Particle Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Embolization Particle Market Size by Application
- 11.4.1 Middle East & Africa Embolization Particle Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Embolization Particle Revenue by Application (2020-2032)
- 11.5 Middle East Embolization Particle Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Embolization Particle Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Embolization Particle Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Embolization Particle Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Embolization Particle Average Sales Price by Manufacturers (2021-2025)
- 12.2 Embolization Particle Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Embolization Particle Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Sirtex Medical
- 13.1.1 Sirtex Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Sirtex Medical Embolization Particle Product Portfolio
- 13.1.3 Sirtex Medical Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Merit Medical
- 13.2.1 Merit Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Merit Medical Embolization Particle Product Portfolio
- 13.2.3 Merit Medical Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Cook Medical
- 13.3.1 Cook Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Cook Medical Embolization Particle Product Portfolio
- 13.3.3 Cook Medical Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 BTG Medical
- 13.4.1 BTG Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 BTG Medical Embolization Particle Product Portfolio
- 13.4.3 BTG Medical Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Boston Scientific Corporation
- 13.5.1 Boston Scientific Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Boston Scientific Corporation Embolization Particle Product Portfolio
- 13.5.3 Boston Scientific Corporation Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Terumo Corporation
- 13.6.1 Terumo Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Terumo Corporation Embolization Particle Product Portfolio
- 13.6.3 Terumo Corporation Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 INterface BIOmaterials B.V.
- 13.7.1 INterface BIOmaterials B.V. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
- 13.7.3 INterface BIOmaterials B.V. Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 HENGRUI Medical
- 13.8.1 HENGRUI Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 HENGRUI Medical Embolization Particle Product Portfolio
- 13.8.3 HENGRUI Medical Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 Alicon
- 13.9.1 Alicon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Alicon Embolization Particle Product Portfolio
- 13.9.3 Alicon Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Embolization Particle Industry Chain Analysis
- 14.2 Embolization Particle Industry Raw Material and Suppliers Analysis
- 14.2.1 Embolization Particle Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Embolization Particle Typical Downstream Customers
- 14.4 Embolization Particle Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
